{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:35:10Z","timestamp":1793738110073,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Biological Dynamics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pancreatic ductal adenocarcinoma (PDAC) has an overall 5-year survival rate of just 12.5% and thus is among the leading causes of cancer deaths. When detected at early stages, PDAC survival rates improve substantially. Testing high-risk patients can increase early-stage cancer detection; however, currently available liquid biopsy approaches lack high sensitivity and may not be easily accessible.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Extracellular vesicles (EVs) were isolated from blood plasma that was collected from a training set of 650 patients (105 PDAC stages I and II, 545 controls). EV proteins were analyzed using a machine learning approach to determine which were the most informative to develop a classifier for early-stage PDAC. The classifier was tested on a validation cohort of 113 patients (30 PDAC stages I and II, 83 controls).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The training set demonstrates an AUC of 0.971 (95% CI\u2009=\u20090.953\u20130.986) with 93.3% sensitivity (95% CI: 86.9\u201396.7) at 91.0% specificity (95% CI: 88.3\u201393.1). The trained classifier is validated using an independent cohort (30 stage I and II cases, 83 controls) and achieves a sensitivity of 90.0% and a specificity of 92.8%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Liquid biopsy using EVs may provide unique or complementary information that improves early PDAC and other cancer detection. EV protein determinations herein demonstrate that the AC Electrokinetics (ACE) method of EV enrichment provides early-stage detection of cancer distinct from normal or pancreatitis controls.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-023-00351-4","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:03:30Z","timestamp":1697709810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-0403","authenticated-orcid":false,"given":"Juan Pablo","family":"Hinestrosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-2413","authenticated-orcid":false,"given":"Rosalie C.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmeet","family":"Dhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6978-5166","authenticated-orcid":false,"given":"Jean M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9723-7789","authenticated-orcid":false,"given":"Gregor","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath I.","family":"Balcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-3264","authenticated-orcid":false,"given":"Dove","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett C.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-1214","authenticated-orcid":false,"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-0537","authenticated-orcid":false,"given":"Paul R.","family":"Billings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"351_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"351_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood, L. D., Canto, M. I., Jaffee, E. M. & Simeone, D. M. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163, 386\u2013402.e381 (2022).","journal-title":"Gastroenterology"},{"key":"351_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park, W., Chawla, A. & O\u2019Reilly, E. M. Pancreatic cancer: a review. J. Am. Med. Assoc. 326, 851\u2013862 (2021).","journal-title":"J. Am. Med. Assoc."},{"key":"351_CR4","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff, J. et al. Pancreatic cancer. Nat. Rev. Dis. Primers 2, 16022 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"351_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3322\/caac.21626","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg, A. J. et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J. Clin. 70, 375\u2013403 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"351_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins, M. et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 69, 7\u201317 (2020).","journal-title":"Gut."},{"key":"351_CR7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gutjnl-2020-323611","volume":"71","author":"KA Overbeek","year":"2022","unstructured":"Overbeek, K. A. et al. Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut. 71, 1152\u20131160 (2022).","journal-title":"Gut."},{"key":"351_CR8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi, J. D., Surana, R., Valle, J. W. & Shroff, R. T. Pancreatic cancer. Lancet 395, 2008\u20132020 (2020).","journal-title":"Lancet"},{"key":"351_CR9","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1200\/JCO.22.01287","volume":"40","author":"MB Yurgelun","year":"2022","unstructured":"Yurgelun, M. B. Building on more than 20 years of progress in pancreatic cancer surveillance for high-risk individuals. J. Clin. Oncol. 40, 3230\u20133234 (2022).","journal-title":"J. Clin. Oncol."},{"key":"351_CR10","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi, A. D., Koay, E. J., Chari, S. T. & Maitra, A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology 156, 2024\u20132040 (2019).","journal-title":"Gastroenterology"},{"key":"351_CR11","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1200\/JCO.22.00194","volume":"40","author":"DCF Klatte","year":"2022","unstructured":"Klatte, D. C. F. et al. Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up. J. Clin. Oncol. 40, 3267\u20133277 (2022).","journal-title":"J. Clin. Oncol."},{"key":"351_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.pan.2021.01.017","volume":"21","author":"M Dbouk","year":"2021","unstructured":"Dbouk, M. et al. Guidelines on management of pancreatic cysts detected in high-risk individuals: an evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements. Pancreatology 21, 613\u2013621 (2021).","journal-title":"Pancreatology"},{"key":"351_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/jrh.12498","volume":"36","author":"JE Segel","year":"2020","unstructured":"Segel, J. E., Hollenbeak, C. S. & Gusani, N. J. Rural-urban disparities in pancreatic cancer stage of diagnosis: understanding the interaction with medically underserved areas. J. Rural Health 36, 476\u2013483 (2020).","journal-title":"J. Rural Health"},{"key":"351_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10027-2","volume":"22","author":"SH Jeong","year":"2022","unstructured":"Jeong, S. H. et al. Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study. BMC Cancer 22, 925 (2022).","journal-title":"BMC Cancer"},{"key":"351_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85759-5","volume":"11","author":"VHF de Jesus","year":"2021","unstructured":"de Jesus, V. H. F. et al. Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of S\u00e3o Paulo, Brazil. Sci. Rep. 11, 6346 (2021).","journal-title":"Sci. Rep."},{"key":"351_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/genes12030349","volume":"12","author":"I Martins","year":"2021","unstructured":"Martins, I. et al. Liquid biopsies: applications for cancer diagnosis and monitoring. Genes 12, 349 (2021).","journal-title":"Genes"},{"key":"351_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000478018","volume":"40","author":"S Mader","year":"2017","unstructured":"Mader, S. & Pantel, K. Liquid biopsy: current status and future perspectives. Oncol Res. Treat. 40, 404\u2013408 (2017).","journal-title":"Oncol Res. Treat."},{"key":"351_CR18","doi-asserted-by":"publisher","first-page":"8678","DOI":"10.3748\/wjg.v21.i28.8678","volume":"21","author":"C Lu","year":"2015","unstructured":"Lu, C. et al. Screening for pancreatic cancer in familial high-risk individuals: a systematic review. World J. Gastroenterol. 21, 8678\u20138686 (2015).","journal-title":"World J. Gastroenterol."},{"key":"351_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-017-0039-5","volume":"1","author":"E Heitzer","year":"2017","unstructured":"Heitzer, E., Perakis, S., Geigl, J. B. & Speicher, M. R. The potential of liquid biopsies for the early detection of cancer. NPJ Precis. Oncol. 1, 36 (2017).","journal-title":"NPJ Precis. Oncol."},{"key":"351_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/aps.2017.162","volume":"39","author":"S Samanta","year":"2018","unstructured":"Samanta, S. et al. Exosomes: new molecular targets of diseases. Acta Pharmacol. Sin. 39, 501\u2013513 (2018).","journal-title":"Acta Pharmacol. Sin."},{"key":"351_CR21","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"351_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","volume":"33","author":"DK Jeppesen","year":"2023","unstructured":"Jeppesen, D. K., Zhang, Q., Franklin, J. L. & Coffey, R. J. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 33, 667\u2013681 (2023).","journal-title":"Trends Cell Biol."},{"key":"351_CR23","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"351_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino, A. et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell 182, 1044\u20131061.e1018 (2020).","journal-title":"Cell"},{"key":"351_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","volume":"5","author":"B Zhou","year":"2020","unstructured":"Zhou, B. et al. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct. Target. Ther. 5, 144 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"351_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","volume":"32","author":"W Yu","year":"2021","unstructured":"Yu, W. et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann. Oncol. 32, 466\u2013477 (2021).","journal-title":"Ann. Oncol."},{"key":"351_CR27","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.7150\/ijbs.35823","volume":"15","author":"X-Y Guo","year":"2019","unstructured":"Guo, X.-Y. et al. Exosomes and pancreatic diseases: status, challenges, and hopes. Int. J. Biol. Sci. 15, 1846\u20131860 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"351_CR28","doi-asserted-by":"crossref","unstructured":"Chen, K., Wang, Q., Kornmann, M., Tian, X. & Yang, Y. The role of exosomes in pancreatic cancer from bench to clinical application: an updated review. Front. Oncol. 11, 644358 (2021).","DOI":"10.3389\/fonc.2021.644358"},{"key":"351_CR29","doi-asserted-by":"crossref","unstructured":"Hinestrosa, J. P. et al. Simultaneous isolation of circulating nucleic acids and EV-associated protein biomarkers from unprocessed plasma using an AC electrokinetics-based platform. Front. Bioeng. Biotechnol. 8, 581157 (2020).","DOI":"10.3389\/fbioe.2020.581157"},{"key":"351_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s43856-022-00088-6","volume":"2","author":"JP Hinestrosa","year":"2022","unstructured":"Hinestrosa, J. P. et al. Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test. Commun. Med. 2, 29 (2022).","journal-title":"Commun. Med."},{"key":"351_CR31","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/elps.201400016","volume":"35","author":"A Sonnenberg","year":"2014","unstructured":"Sonnenberg, A. et al. Dielectrophoretic isolation and detection of cancer-related circulating cell-free DNA biomarkers from blood and plasma. Electrophoresis 35, 1828\u20131836 (2014).","journal-title":"Electrophoresis"},{"key":"351_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/ijh-2015-0009","volume":"5","author":"S Manouchehri","year":"2016","unstructured":"Manouchehri, S. et al. Dielectrophoretic recovery of DNA from plasma for the identification of chronic lymphocytic leukemia point mutations. Int. J. Hematol. Oncol. 5, 27\u201335 (2016).","journal-title":"Int. J. Hematol. Oncol."},{"key":"351_CR33","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/acsnano.7b08199","volume":"12","author":"JM Lewis","year":"2018","unstructured":"Lewis, J. M. et al. Integrated analysis of exosomal protein biomarkers on alternating current electrokinetic chips enables rapid detection of pancreatic cancer in patient blood. ACS Nano 12, 3311\u20133320 (2018).","journal-title":"ACS Nano"},{"key":"351_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46311-8","volume":"9","author":"J Lewis","year":"2019","unstructured":"Lewis, J. et al. A pilot proof-of-principle analysis demonstrating dielectrophoresis (DEP) as a glioblastoma biomarker platform. Sci. Rep. 9, 10279 (2019).","journal-title":"Sci. Rep."},{"key":"351_CR35","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1021\/acsnano.7b00549","volume":"11","author":"SD Ibsen","year":"2017","unstructured":"Ibsen, S. D. et al. Rapid isolation and detection of exosomes and associated biomarkers from plasma. ACS Nano 11, 6641\u20136651 (2017).","journal-title":"ACS Nano"},{"key":"351_CR36","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1002\/smll.201570233","volume":"11","author":"S Ibsen","year":"2015","unstructured":"Ibsen, S. et al. Nanoparticles: recovery of drug delivery nanoparticles from human plasma using an electrokinetic platform technology (Small 38\/2015). Small 11, 4990\u20134990 (2015).","journal-title":"Small"},{"key":"351_CR37","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. Machine learning protocols in early cancer detection based on liquid biopsy: a survey. Life 11, 638 (2021).","DOI":"10.3390\/life11070638"},{"key":"351_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cgh.2021.08.010","volume":"20","author":"NP Chalasani","year":"2022","unstructured":"Chalasani, N. P. et al. Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 20, 173\u2013182.e177 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"351_CR39","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"351_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","volume":"112","author":"AL Blackford","year":"2020","unstructured":"Blackford, A. L., Canto, M. I., Klein, A. P., Hruban, R. H. & Goggins, M. Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis. JNCI J. Natl. Cancer Inst. 112, 1162\u20131169 (2020).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"351_CR41","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1245\/s10434-018-6832-8","volume":"25","author":"V Muralidhar","year":"2018","unstructured":"Muralidhar, V. et al. Association between very small tumor size and decreased overall survival in node-positive pancreatic cancer. Ann. Surg. Oncol. 25, 4027\u20134034 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"351_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4610-4","volume":"18","author":"AM Saad","year":"2018","unstructured":"Saad, A. M., Turk, T., Al-Husseini, M. J. & Abdel-Rahman, O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer 18, 688 (2018).","journal-title":"BMC Cancer"},{"key":"351_CR43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/cancers13040769","volume":"13","author":"LE Kane","year":"2021","unstructured":"Kane, L. E., Mellotte, G. S., Conlon, K. C., Ryan, B. M. & Maher, S. G. Multi-Omic biomarkers as potential tools for the characterisation of pancreatic cystic lesions and cancer: innovative patient data integration. Cancers 13, 769 (2021).","journal-title":"Cancers"},{"key":"351_CR44","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.2147\/OTT.S100510","volume":"9","author":"DS Swords","year":"2016","unstructured":"Swords, D. S., Firpo, M. A., Scaife, C. L. & Mulvihill, S. J. Biomarkers in pancreatic adenocarcinoma: current perspectives. Onco Targets Ther. 9, 7459\u20137467 (2016).","journal-title":"Onco Targets Ther."},{"key":"351_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.dld.2015.11.001","volume":"48","author":"N Le","year":"2016","unstructured":"Le, N. et al. Prognostic and predictive markers in pancreatic adenocarcinoma. Dig. Liver Dis. 48, 223\u2013230 (2016).","journal-title":"Dig. Liver Dis."},{"key":"351_CR46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.pan.2018.08.003","volume":"18","author":"G Luo","year":"2018","unstructured":"Luo, G. et al. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer. Pancreatology 18, 971\u2013976 (2018).","journal-title":"Pancreatology"},{"key":"351_CR47","first-page":"340","volume":"13","author":"KE Poruk","year":"2013","unstructured":"Poruk, K. E. et al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr. Mol. Med. 13, 340\u2013351 (2013).","journal-title":"Curr. Mol. Med."},{"key":"351_CR48","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1053\/j.gastro.2020.11.052","volume":"160","author":"JF Fahrmann","year":"2021","unstructured":"Fahrmann, J. F. et al. Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. Gastroenterology 160, 1373\u20131383.e1376 (2021).","journal-title":"Gastroenterology"},{"key":"351_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen, S. Y. et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563, 579\u2013583 (2018).","journal-title":"Nature"},{"key":"351_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24994-w","volume":"12","author":"D Mathios","year":"2021","unstructured":"Mathios, D. et al. Detection and characterization of lung cancer using cell-free DNA fragmentomes. Nat. Commun. 12, 5060 (2021).","journal-title":"Nat. Commun."},{"key":"351_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu, M. C. et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745\u2013759 (2020).","journal-title":"Ann. Oncol."},{"key":"351_CR52","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein, E. A. et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann. Oncol. 32, 1167\u20131177 (2021).","journal-title":"Ann. Oncol."},{"key":"351_CR53","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"351_CR54","doi-asserted-by":"publisher","first-page":"e00468","DOI":"10.14309\/ctg.0000000000000468","volume":"13","author":"RE Brand","year":"2022","unstructured":"Brand, R. E. et al. Detection of early-stage pancreatic ductal adenocarcinoma from blood samples: results of a multiplex biomarker signature validation study. Clin. Transl. Gastroenterol. 13, e00468 (2022).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"351_CR55","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura, K. et al. An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study. Gastroenterology 163, 1252\u20131266.e1252 (2022).","journal-title":"Gastroenterology"},{"key":"351_CR56","doi-asserted-by":"publisher","first-page":"2102789","DOI":"10.1002\/advs.202102789","volume":"8","author":"L Min","year":"2021","unstructured":"Min, L. et al. Advanced nanotechnologies for extracellular vesicle-based liquid biopsy. Adv. Sci. 8, 2102789 (2021).","journal-title":"Adv. Sci."},{"key":"351_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neo.2020.11.011","volume":"23","author":"MP Bebelman","year":"2021","unstructured":"Bebelman, M. P., Janssen, E., Pegtel, D. M. & Crudden, C. The forces driving cancer extracellular vesicle secretion. Neoplasia 23, 149\u2013157 (2021).","journal-title":"Neoplasia"},{"key":"351_CR58","doi-asserted-by":"crossref","unstructured":"Huang, D., Rao, D., Xi, X., Zhang, Z. & Zhong, T. Application of extracellular vesicles proteins in cancer diagnosis. Front. Cell Dev. Biol. 10, 1007360 (2022).","DOI":"10.3389\/fcell.2022.1007360"},{"key":"351_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335 (2015).","journal-title":"Nature"},{"key":"351_CR60","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","volume":"23","author":"EI Buzas","year":"2023","unstructured":"Buzas, E. I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 23, 236\u2013250 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"351_CR61","doi-asserted-by":"publisher","first-page":"10279","DOI":"10.1111\/jcmm.15684","volume":"24","author":"S Wang","year":"2020","unstructured":"Wang, S., You, L., Dai, M. & Zhao, Y. Mucins in pancreatic cancer: a well-established but promising family for diagnosis, prognosis and therapy. J. Cell. Mol. Med. 24, 10279\u201310289 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"351_CR62","doi-asserted-by":"crossref","unstructured":"Lin, T. C. & Hsiao, M. Leptin and cancer: updated functional roles in carcinogenesis, therapeutic niches, and developments. Int. J. Mol. Sci. 22, 2870 (2021).","DOI":"10.3390\/ijms22062870"},{"key":"351_CR63","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1126\/science.aax9341","volume":"364","author":"CJ Halbrook","year":"2019","unstructured":"Halbrook, C. J. & Crawford, H. C. Hiding in plain sight. Science 364, 1132\u20131133 (2019).","journal-title":"Science"},{"key":"351_CR64","doi-asserted-by":"publisher","first-page":"16120","DOI":"10.18632\/oncotarget.3878","volume":"6","author":"Y Fan","year":"2015","unstructured":"Fan, Y. et al. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget 6, 16120\u201316134 (2015).","journal-title":"Oncotarget"},{"key":"351_CR65","doi-asserted-by":"crossref","unstructured":"Chen, W. et al. MUC1: structure, function, and clinic application in epithelial cancers. Int. J. Mol. Sci. 22, 6567 (2021).","DOI":"10.3390\/ijms22126567"},{"key":"351_CR66","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fonc.2020.00476","volume":"10","author":"RAM Brown","year":"2020","unstructured":"Brown, R. A. M. et al. Altered iron metabolism and impact in cancer biology, metastasis, and immunology. Front. Oncol. 10, 476 (2020).","journal-title":"Front. Oncol."},{"key":"351_CR67","doi-asserted-by":"publisher","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","volume":"20","author":"AE Becker","year":"2014","unstructured":"Becker, A. E., Hernandez, Y. G., Frucht, H. & Lucas, A. L. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J. Gastroenterol. 20, 11182\u201311198 (2014).","journal-title":"World J. Gastroenterol."},{"key":"351_CR68","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1245\/s10434-021-11258-6","volume":"29","author":"AL Fonseca","year":"2022","unstructured":"Fonseca, A. L. et al. Disparities in access to oncologic care in pancreatic cancer: a systematic review. Ann. Surg. Oncol. 29, 3232\u20133250 (2022).","journal-title":"Ann. Surg. Oncol."},{"key":"351_CR69","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.3390\/jcm9113720","volume":"9","author":"M Vujasinovic","year":"2020","unstructured":"Vujasinovic, M. et al. Risk of developing pancreatic cancer in patients with chronic pancreatitis. J. Clin. Med. 9, 3720 (2020).","journal-title":"J. Clin. Med."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00351-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T11:38:26Z","timestamp":1700221106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00351-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.H., H.D., J.M.L., H.I.B., and P.R.B. are current employees of Biological Dynamics. G.S. is a former employee of Biological Dynamics. J.P.H. is a named inventor in patents held by Biological Dynamics. R.C.S. received support from NCI R01 CA186241, U01 CA224012, U01 CA278923; Department of Defense PA210068; and the Brenden-Colson Center Foundation, and is a consultant for Larkspur Biosciences, a member of the scientific advisory board of RAPPTA Therapeutics and has received sponsored research support from Cardiff Oncology, AstraZeneca Partner of Choice grant award. R.K. is s funded in part by 5U01CA180888-08 and 5UG1CA233198-05. R.K. has received research funding from Boehringer Ingelheim, Debiopharm, Foundation Medicine, Genentech, Grifols, Guardant, Incyte, Konica Minolta, Medimmune, Merck Serono, Omniseq, Pfizer, Sequenom, Takeda, and TopAlliance and from the NCI; as well as consultant and\/or speaker fees and\/or advisory board\/consultant for Actuate Therapeutics, AstraZeneca, Bicara Therapeutics, Inc., Biological Dynamics, Caris, Datar Cancer Genetics, Daiichi, EISAI, EOM Pharmaceuticals, Iylon, LabCorp, Merck, NeoGenomics, Neomed, Pfizer, Prosperdtx, Regeneron, Roche, TD2\/Volastra, Turning Point Therapeutics, X-Biotech; has an equity interest in CureMatch Inc. and IDbyDNA; serves on the Board of CureMatch and CureMetrix, and is a co-founder of CureMatch. B.C.S. received support from NCI U01 CA278923 and the Brenden-Colson Center Foundation. D.K. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}